Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Both manufacturing facilities are based out of Benguluru, India
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Subscribe To Our Newsletter & Stay Updated